Overview

Quantification of the Dipeptidyl Peptidase (DPP)-4 Inhibition-mediated Enhancement of the Activity of the Entero-insular Axis

Status:
Completed

Trial end date:
2013-12-01

Target enrollment:

Participant gender:

Summary

Objective: To assess the effect if co-administration of sitagliptin and metformin compared to placebo on the incretin effect (based on the comparison of the insulin secretory response to oral glucose load and an 'isoglycaemic' intravenous glucose load). Hypothesis: Treatment with co-administration of sitagliptin and metformin provides a greater incretin effect compared to placebo.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Michael A. Nauck

Treatments:

Metformin
Sitagliptin Phosphate